home / stock / bsem / bsem news

BSEM News and Press, BioStem Technologies Inc From 08/25/21

Stock Information
Company Name: BioStem Technologies Inc
Stock Symbol: BSEM
Market: OTC
Website: biostemtechnologies.com
Menu
BSEM BSEM Quote BSEM Short BSEM News BSEM Articles BSEM Message Board
Get BSEM Alerts

News, Short Squeeze, Breakout and More Instantly...
BSEM - BioStem Technologies Reports Record Breaking Second Quarter Sales

Company on P ace to E xceed 2020 Revenues in 2021 Pompano Beach, Fl., Aug. 25, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue allografts for use in re...
BSEM - BioStem Technologies, Inc., Announces the Engagement of Biologics Consulting To Support FDA Strategies and Submissions.

Pompano Beach, Fl., July 27, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing elements of perinatal tissue for use in regenerative therapies; announced today that it has engage...

BSEM - BioStem Technologies, Inc. Awarded Q Code for VENDAJE® Product Line From CMS.

Pompano Beach, Fl., July 23, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing elements of perinatal tissue for use in regenerative therapies; announces that the Centers for Med...

BSEM - BioStem Technologies reports Q1 results

BioStem Technologies (BSEM): Q1 Net loss of $0.29M.Revenue of $0.95M (+21.8% Y/Y)Press Release For further details see: BioStem Technologies reports Q1 results

BSEM - BioStem Technologies Announces Filing of 2021 First Quarter Financial Reports

Pompano Beach, Fl., May 24, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue allografts for use in regenerative therapies, today announced that it has filed its first quarter f...

BSEM - BioStem Technologies, Inc., Announces the Addition of Three Key Scientific Advisory Board Members

Pompano Beach, Fl., April 20, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing elements of perinatal tissue for use in regenerative therapies; today announced that it has appoi...

BSEM - BioStem Technologies, Inc. Announces Launch of National Sales Force Expansion

Pompano Beach, Fl., April 15, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing elements of perinatal tissue for use in regenerative therapies, today announced the launch of a n...
BSEM - BioStem Technologies, Inc. reports Q4 results

BioStem Technologies, Inc. (BSEM): Q4 Revenue of $1.04M (+147.6% Y/Y)Press Release For further details see: BioStem Technologies, Inc. reports Q4 results

BSEM - BioStem Technologies, Inc. Reports Financial Results for Fourth Quarter and Fiscal Year 2020

Pompano Beach, Fl., April 05, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading pre-clinical-stage biotechnology company focused on harnessing elements of perinatal tissue for use in regenerative therapies, today reported financial ...

BSEM - BioStem Technologies, Inc. Receives TRIP (TRG Rapid Inquiry Program) Response for VENDAJE(TM)

Pompano Beach, Fl., March 25, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing elements of perinatal tissue for use in regenerative therapies, today announced that it has recei...
Previous 10 Next 10